COLLABORATION OF GROWTH FACTOR AND ONCOGENE PRODUCT IN HEPATOCARCINOGENESIS AND LIVER REGENERATION -ANALYSIS BY DOUBLE TRANSGENIC MICE-
COLLABORATION OF GROWTH FACTOR AND ONCOGENE PRODUCT IN HEPATOCARCINOGENESIS AND LIVER REGENERATION -ANALYSIS BY DOUBLE TRANSGENIC MICE-
批准号:
09670510
负责人:
TAKAGI Hitoshi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
转化生长因子(TGF) α和原癌基因ras通过酪氨酸激酶的激活参与细胞内信号转导。我们和其他研究小组独立开发了TGFalpha转基因小鼠(T)和ras转基因小鼠(R),这两种转基因小鼠都表现出特征性表型,如(T)的肝细胞癌、胰腺纤维化和(R)的脾肉瘤和皮肤乳头瘤。我们制备了TGFalpha和ras(T+R)双转基因小鼠,并对其表型、肿瘤形成和肝脏再生进行了分析。首先,T+R的体重低于T和R的体重和肝脏重量的提供率!T+R组体重明显高于单纯T或R组。出生后12个月,15例T+R组中有4例出现大肝癌和腺瘤。15例中有4例(R)发生皮肤乳头状瘤,15例中有2例(T)发生肝腺瘤。T+R肝癌组织中超过10%的肝细胞被增殖细胞核抗原(PCNA)阳性染色,约1%的T+R非肿瘤组织被PCNA阳性染色。另一方面,非肿瘤肝脏的PCNA显示不到1%。与T和R相比,T+R显示2/3肝切除术后肝脏再生增强。皮肤肿瘤和脾肉瘤在T+R组与R组相比没有增强,胰腺重量比T重,胰腺纤维化在T+R组比T或R组增强,TGFa和ras同时过表达抑制小鼠生长,促进肝脏生长,肝脏肿瘤形成和再生。TGFalpha和ras也增强了胰腺纤维化,导致胰腺生长增强。
英文摘要
Transforming growth factor(TGF)alpha and protooncogene ras are involved inthe intracellular signal transduction through the activation of tyrosine kinase.We and other group have developed TGFalpha transgenic mice(T) and ras transgenicmice(R) independently, Both of the transgenic mice showed characteristicphenotypes e.g. hepatocellular carcinoma, pancreatic fibrosis for (T) andsplenic sarcoma and skin papilloma for (R). We made the double transgenic miceof TGFalpha and ras(T+R) and analyzed the phenotype, tumor formation, and liverregeneration. First of all, T+R had lower body weight than T and R and the rate ofliver weight! body weight was significantly higher in T+R than single T or R.Large hepato cellular carcinoma and adenoma were observed in 4 of 15 T+R 12months after birth. Four of 15(R) developed skin papilloma and 2 of 15 (T) didhepatic adenoma. More than 10% of hepatocytes were positively stained byproliferating cell nuclear antigen(PCNA) in liver tumors of T+R and about 1% ofnon-tumor tissue of T+R.On the other hand, non-tumor liver showed less than1% by PCNA.Compared with T and R, T+R showed enhanced regeneration of theliver after 2/3 hepatectomy. Skin tumor and splenic sarcoma was not enhancedin T+R compared with R.he weight of pancreas was heavier in T+R than T or Rand pancreatic fibrosis was enhanced in T+R than T or R.Thus simultaneous overexpression of TGFa and ras inhibited the growth ofthe mice and enhanced the growth of the liver, hepatic tumor formation andregeneration. Pancreatic fibrosis was also enhanced by TGFalpha and ras, resultingin enhanced growth of pancreas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takayama H,et al: "Analysis of the hepatic and gastrointestinal phenotype of HGF/SF transgenic mice.(in Japanese)" Frontiers in Gastroenterology. 2. 252-260 (1997)
Takayama H 等人:“HGF/SF 转基因小鼠的肝脏和胃肠道表型分析。(日语)”胃肠病学前沿。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takagi H,et al.: "The effects high dose intereron-α in patients with hepatitis C-in view of hypervariable of HCV-." FIRST INTERNATIONAL SYMPOSIUM ON VIRAL HEPATITIS.supple.1.Supple.7-10 (1998)
Takagi H 等人:“考虑到 HCV 的高变性,高剂量 Intereron-α 对丙型肝炎患者的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ichikawa T,et al.: "Quantitative analysis of hepatitis B virus precore mutant in hepatitis B." TOHOKU J Exp.Med.186. 323-333 (1998)
Ichikawa T 等人:“乙型肝炎病毒前核突变体的定量分析”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takagi H, et al: "Steroid hormone-dependent overexpression of cytochrome p450 2A in liver tumor of TGFα transgenic mice." J Gastroenterol. 32. 708-711 (1997)
Takagi H 等人:“TGFα 转基因小鼠肝脏肿瘤中细胞色素 p450 2A 的类固醇激素依赖性过度表达。” J Gastroenterol。 32. 708-711 (1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sohara N,et al.: "Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrchrolide."
Sohara N,et al.:“肝细胞癌患者动脉化疗栓塞引起的恶心和呕吐以及盐酸昂丹司琼的止吐作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
Development of low-cost extraction method for cellulose nanofiber from paper sludge and application to biocomposites
-
批准号:24656394
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2012
-
负责人:TAKAGI Hitoshi
-
依托单位:
Clinical evidence-based investigation of developmental mechanism in diabetic retinopathy
-
批准号:23592594
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2011
-
负责人:TAKAGI Hitoshi
-
依托单位:
Development of nano cellulose fiber green composites fabricated by combining controlled solidification and freeze-drying
-
批准号:20560642
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:TAKAGI Hitoshi
-
依托单位:
Combination therapy of apoptosis induction and molecular targeting for hepatocellular carcinoma. -Transgenic mice study-
-
批准号:15590619
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2003
-
负责人:TAKAGI Hitoshi
-
依托单位:
The pathological investigation of proliferative diabetic retinopathy based on the control of retinal pericytes
-
批准号:12470363
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2000
-
负责人:TAKAGI Hitoshi
-
依托单位:
A study on the production of high temperature supercomposites and strengthening by mesoscopic structural controlling
-
批准号:11650709
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TAKAGI Hitoshi
-
依托单位:
ANALYSIS OF GASTRIC MUCOSAL PROLIFERATION USING THE GROWTH FACTOR TRANSGENIC MICE
-
批准号:11670475
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:TAKAGI Hitoshi
-
依托单位:
Development of gene therapy for retinal neovascular disorders by controlling expression of VEGF
-
批准号:09470378
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.0万
-
财政年份:1997
-
负责人:TAKAGI Hitoshi
-
依托单位:
THE STUDY OF SEX DIFFERENCE IN HEPATOCARCINOGENESIS-ANALYSIS USING TGF alpha TRANSGENIC MICE-
-
批准号:07670562
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:TAKAGI Hitoshi
-
依托单位:
Is the U.S.Banking Industry in Decline?
-
批准号:07630090
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:TAKAGI Hitoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
槲皮素基于P53/Ras调控细胞凋亡增殖抗OSF癌变的机制研究
-
批准号:2026JJ82512
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王韧
-
依托单位:
lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:施文标
-
依托单位:
组织驻留菌Eggerthella lenta 通过代
谢重编程Ras通路介导的细胞凋亡抑制结
直肠癌的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:陈一纬
-
依托单位:
新型污染物三(2-氯丙基)磷酸酯通过RAS/NLRP3信号通路致肾纤维化机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李升
-
依托单位:
赛沃替尼+西妥昔单抗+FOLFOX化疗对比西妥昔单抗+FOLFOX化疗一线治疗RAS/BRAF野生型转移性结直肠癌:一项前瞻性随机、对照、多中心、开放性研究
-
批准号:25SF1901600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:许剑民
-
依托单位:
氨基酸突变Ras构象和作用机理的深入分
析导向肿瘤药物发现
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:曾娟
-
依托单位:
生育三烯酚调节RAS-ERK-MAPK通路促糖尿病溃疡愈合的机制研究
-
批准号:2025JJ80977
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:兰宏伟
-
依托单位:
全基因组CRISPR-Cas9筛选RAS/MAPK信号通路失活诱导非小细胞肺癌第三代EGFR-TKI耐药机制研究
-
批准号:JCZRLH202500317
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
牙周膜应力介导RAS信号通路调控破骨细胞增殖和分化促进牙周辅助加速正畸的机制研究
-
批准号:2025JJ70585
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黄勉芳
-
依托单位: